Midecamycin

Research use only, not for human use.

Midecamycin an acetoxy-substituted macrolide antibiotic has effective on gram-positive and gram-negative bacteria acts by inhibiting bacterial protein synthesis.

Midecamycin an acetoxy-substituted macrolide antibiotic has effective on gram-positive and gram-negative bacteria acts by inhibiting bacterial protein synthesis.(In Vitro):Midecamycin inhibits the majority of streptococci, staphylococci, and strains of Haemophilus and Listeria at concentrations of less than 3.1 μg/mL. Midecamycin is a 16-membered macrolide. Midecamycin is a new macrolide antibiotic, which is produced by Streptomyces mycarofaciens.

Midecamycin inhibits the majority of streptococci, staphylococci, and strains of Haemophilus and Listeria at concentrations of less than 3.1 μg/mL. Midecamycin is a 16-membered macrolide. Midecamycin is a new macrolide antibiotic, which is produced by Streptomyces mycarofaciens.

——

Antibiotic SF-837 | Espinomycin A | Medecamycin A1 | Platenomycin B1 | Rubimycin | Turimycin P3

GPCR/G Protein

Antibacterial

Antibacterial

Inflammation/Immunology

infections in the oral cavity upper and lower respiratory tracts and skin and soft tissue infections.

35457-80-8

813.97

C41H67NO15

>98% (HPLC)

DMSO: 50 mg/mL;Ethanol: 50 mg/mL;Water: Insoluble

CCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)O)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](OC(=O)CC)[C@@H]2OC)[C@H](O)[C@H]1N(C)C

7-(Formylmethyl)-410-dihydroxy-5-methoxy-916-dimethyl-2-oxooxacyclohexadeca-1113-dien-6-yl 36-dideoxy-4-O-(26-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranoside 4'4''-dipropionate (ester)

(-20℃)

With Ice Pack

≥ 2 years